Hims & Hers Health, Inc. (HIMS) stock analysis

HIMS · Hims & Hers Health, Inc.

Latest recorded price: USD 18.56

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

A reliable intrinsic value could not be calculated for HIMS; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 64.5%, free cash flow margin 3.2%, ROIC 7.0%. The model flags 1 risk signal for this company.

Similar companies in Healthcare